Keywords: EM, erythema multiforme; IL, interleukin; LP, lichen planus; MMP, mucous membrane pemphigoid; PV, pemphigus vulgaris; TNF-α, tumor necrosis factor-α; drug eruption; interleukin-17; lichenoid mucositis; secukinumab; tumor necrosis factor-α.